Avoro Capital Advisors LLC Avidity Biosciences, Inc. Transaction History

Avoro Capital Advisors LLC

$6.65 Billion
Q3 2024

A detailed history of Avoro Capital Advisors LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 6,875,000 shares of RNA stock, worth $207 Million. This represents 4.75% of its overall portfolio holdings.

Number of Shares

6,875,000

Previous 6,505,000 5.69%

Holding current value

$207 Million

Previous $266 Million 18.83%

% of portfolio

4.75%

Previous 3.63%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$37.21 - $48.14 $13.8 Million - $17.8 Million	370,000 Added 5.69%	6,875,000 $316 Million
Q2 2024 Aug 14, 2024	BUY	$22.73 - $40.85 $15.5 Million - $27.8 Million	680,000 Added 11.67%	6,505,000 $266 Million
Q1 2024 May 15, 2024	BUY	$9.16 - $25.52 $30.4 Million - $84.6 Million	3,315,000 Added 132.07%	5,825,000 $149 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $7.06 Million - $11.8 Million	460,000 Added 22.44%	2,510,000 $38.5 Million
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $6.04 Million - $13.6 Million	600,000 Added 41.38%	2,050,000 $45.5 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $2.32 Million - $3.51 Million	150,000 Added 11.54%	1,450,000 $23.7 Million
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $994,000 - $1.66 Million	70,000 Added 5.69%	1,300,000 $24 Million
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $1.63 Million - $2.29 Million	80,000 Added 6.96%	1,230,000 $29.2 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $11 Million - $15.3 Million	605,000 Added 111.01%	1,150,000 $28.3 Million
Q3 2020 Nov 16, 2020	SELL	$23.35 - $35.94 $934,000 - $1.44 Million	-40,000 Reduced 6.84%	545,000 $15.3 Million
Q2 2020 Aug 14, 2020	BUY	$26.62 - $31.5 $15.6 Million - $18.4 Million	585,000 New	585,000 $16.5 Million

Others Institutions Holding RNA

# of Institutions

255

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.57B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Avidity Biosciences, Inc. Transaction History